Read More

This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis

William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth, especially in sub-categories such as extremities, which are growing rapidly due to

ENOV